Perrigo to acquire French OTC company HRA Pharma for $2.1bn

Perrigo to acquire French OTC company HRA Pharma for $2.1bn

Perrigo Company plc has agreed to acquire Héra SAS (HRA Pharma), a French consumer self-care company, from funds affiliated with Astorg and Goldman Sachs Asset Management for around $2.1 billion in cash. HRA Pharma is an over-the-counter (OTC) company, which owns specialist blister plaster brand Compeed, ellaOne emergency contraception brand, and Mederma scar care cream. […]

Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn

Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn

Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for about $1.55 billion. The Rx business of Perrigo employs over 1,300 employees in six locations in the US and Israel. Its generic medicines portfolio consists of more than 200 product families and 800 stock-keeping […]

Perrigo acquires skincare and hair loss treatment brands from Sanofi

Perrigo acquires skincare and hair loss treatment brands from Sanofi

Ireland-based Perrigo Company has agreed to acquire three over-the-counter (OTC) skincare and hair loss treatment brands sold across Eastern Europe, namely Emolium, Iwostin, and Loxon, from French pharma giant Sanofi. Financial terms of the deal were not disclosed by the parties. According to Perrigo Company, the products to be acquired have trailing 12 months net […]